M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Blueprint Medicines Corp to acquire Lengo Therapeutics
Announced Dec 30, 2021 · Closed Dec 30, 2021 · Private target
Deal value$250M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash
Transaction
- Acquirer
- Blueprint Medicines Corp (BPMC)
- Target
- Lengo Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Dec 30, 2021
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations